Corrigendum : Alternative splicing promotes tumour aggressiveness and drug resistance in African American prostate cancer

Wang, Bi-Dar and Ceniccola, Kristin and Hwang, SuJin and Andrawis, Ramez and Horvath, Anelia and Freedman, Jennifer A. and Olender, Jacqueline and Knapp, Stefan and Ching, Travers and Garmire, Lana and Patel, Vyomesh and Garcia-Blanco, Mariano A. and Patierno, Steven R. and Lee, Norman H. (2017) Corrigendum : Alternative splicing promotes tumour aggressiveness and drug resistance in African American prostate cancer. Nature Communications, 8. 16161. ISSN 2041-1723 (https://doi.org/10.1038/ncomms16161)

[thumbnail of Wang-etal-NC-2017-Corrigendum-Alternative-splicing-promotes-tumour-aggressiveness-and-drug-resistance]
Preview
 Text. Filename: Wang_etal_NC_2017_Corrigendum_Alternative_splicing_promotes_tumour_aggressiveness_and_drug_resistance.pdf
Final Published Version
License: Creative Commons Attribution 4.0 logo
Download (129kB)| Preview

Abstract

Nature Communications 8: Article number: 15921 (2017); Published: 30 June 2017; Updated: 27 September 2017 Contributions of the author Steven R. Patierno are not fully acknowledged in this Article. The Author Contributions section should have included the following: ‘S.R.P. was involved in the co-conception of the study, and was co-principal investigator of the initial portion of this study by obtaining NCI Center to Reduce Cancer Health Disparities grant supplement U01CA11637-05S2 (to S.R.P.) that supported initial experiments towards differential alternative splicing events, oncogenic splicing pathway, validation of differential alternative splicing and selective knockdown of PIK3CD L and S variants.’

CORE (COnnecting REpositories)